HealthMap

Mechanism of Action in ADHD

• Atomoxetine hydrochloride (Strattera) is classified as a selective norepinephrine reuptake inhibitor (SNRI).
• Unlike conventional stimulants that primarily target dopamine pathways, atomoxetine works by blocking the reuptake of norepinephrine (and to a lesser extent, dopamine) into presynaptic neurons.
• This action significantly increases the extracellular concentration of norepinephrine in the prefrontal cortex, a region of the brain critically involved in attention, working memory, impulse control, and executive function.

Biochemical and Nutritional Considerations

• From an orthomolecular and biochemical perspective, altering neurotransmitter reuptake places a high metabolic demand on the body's amino acid pools and cofactor reserves.
• Neurotransmitters such as norepinephrine are synthesized from precursor amino acids like tyrosine and phenylalanine, utilizing essential vitamins and minerals (such as vitamin C, B-complex vitamins, and copper) as enzymatic cofactors.
• Chronic use of pharmacological reuptake inhibitors can sometimes unmask underlying nutritional deficiencies or alter systemic metabolic pathways if dietary intake and cellular utilization of these vital nutrients are not optimized.

Clinical Implications

• Because atomoxetine relies on existing neurotransmitter synthesis to exert its effects, individual biochemical individuality plays a major role in how well a patient responds.
• Optimal neurological function requires a balanced supply of building blocks; therefore, addressing potential dietary imbalances, digestion, and mineral status is often critical when evaluating long-term management strategies for ADHD.